Sign in
SCHEDULE 13G/A

Statement of Beneficial Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0001388325-26-000011

Stakes reported in this filing

Loading xslSCHEDULE_13G_X01/primary_doc.xml…